• Mifepristone Market Overview
    The Mifepristone Market was valued at $700 million in 2024 and is projected to reach $1.2 billion by 2035, growing at a CAGR of 4.4%. Mifepristone is a progesterone receptor antagonist primarily used for medical abortion, induction of labor, and management of miscarriage. Its increasing acceptance as a safe alternative to surgical procedures drives sustained market demand. The market is...
    0 Comments 0 Shares 116 Views 0 Reviews
  • Mifepristone Market Overview
    The Mifepristone Market was valued at USD 700 million in 2024 and is projected to reach USD 1,200 million by 2035, growing at a CAGR of 4.4%. Mifepristone is a progesterone receptor antagonist primarily used for medical abortion and the management of Cushing's syndrome. The market encompasses various dosage forms including tablets, injectables, and injections, with tablets dominating due to...
    0 Comments 0 Shares 97 Views 0 Reviews